Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Outstanding (2022 - 2025)

Historic Shares Outstanding for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $56.5 million.

  • Orchestra BioMed Holdings' Shares Outstanding rose 4881.5% to $56.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.5 million, marking a year-over-year increase of 4881.5%. This contributed to the annual value of $38.2 million for FY2024, which is 675.57% up from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Shares Outstanding stood at $56.5 million for Q3 2025, which was up 4881.5% from $38.6 million recorded in Q2 2025.
  • Orchestra BioMed Holdings' Shares Outstanding's 5-year high stood at $56.5 million during Q3 2025, with a 5-year trough of $10.1 million in Q1 2022.
  • Over the past 4 years, Orchestra BioMed Holdings' median Shares Outstanding value was $35.8 million (recorded in 2023), while the average stood at $33.8 million.
  • In the last 5 years, Orchestra BioMed Holdings' Shares Outstanding surged by 21313.0% in 2023 and then grew by 22.82% in 2024.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' Shares Outstanding stood at $35.7 million in 2022, then increased by 0.23% to $35.8 million in 2023, then increased by 6.76% to $38.2 million in 2024, then surged by 47.83% to $56.5 million in 2025.
  • Its last three reported values are $56.5 million in Q3 2025, $38.6 million for Q2 2025, and $38.3 million during Q1 2025.